5-Year Impact Factor: 0.9
Volume 34, 12 Issues, 2024
  Original Article     July 2024  

Biochemical and Oxidative Biomarkers in Preeclampsia

By Muhammad Naveed Najeeb1, Umaira Munir2, Nimrah Sattar2, Shakila Yasmin2

Affiliations

  1. Department of Biochemistry, Quaid-e-Azam Medical College, Bahawalpur, Pakistan
  2. Department of Obstetrics and Gynaecology, Quaid-e-Azam Medical College, Bahawalpur, Pakistan
doi: 10.29271/jcpsp.2024.07.780

ABSTRACT
Objective: To determine the biochemical and oxidative stress parameters as biomarkers in preeclampsia.
Study Design: Cross-sectional analytical study.
Place and Duration of the Study: Departments of Obstetrics / Gynaecology and Biochemistry, Quaid-e-Azam Medical College, Bahawalpur, Pakistan, from September 2022 to February 2023.
Methodology: Women with preeclampsia were selected based on blood pressure exceeding 140/90 mmHg and proteinuria levels exceeding 300 mg/24 hours or showing a +1 on a dipstick test. Normotensive pregnant women were selected as controls. Venous blood was taken and centrifuged, and routine biochemical methods were used to estimate serum lipid profile levels and minerals. The estimation of oxidative stress enzymes was carried out manually using special chemicals. Student’s t-test and Pearson’s correlation were applied to analyse the result.
Results: The study included 228 subjects: 114 preeclampsia patients and 114 normal pregnant women as controls. The mean systolic blood pressure was measured at 166.25 mmHg and the diastolic blood pressure was 92.80 mmHg (p <0.001). All lipid profile estimations showed notable abnormalities, but the mean level of triglycerides (TGs) (214.90 ± 15.59 mg/dl) in preeclamptic patients was significantly elevated (p <0.05). In terms of minerals, all were deranged but magnesium (1.37 ± 0.35 mg/dl) and calcium (7.55 ± 0.45 mg/dl) were significantly decreased (p <0.05). All oxidative enzyme levels were increased (p <0.05) but malondialdehyde (MDA) with a mean level of 2.58 ± 0.40 nmol/ml was significantly elevated. The Pearson’s correlation of these parameters with blood pressure also showed a positive association.
Conclusion: Total cholesterol triglyceride in the lipid profile, calcium and magnesium in minerals, and MDA in oxidative parameters were markedly deranged and exhibited significant associations with the severity of the disease, so could be used as disease biomarkers of preeclampsia.

Key Words: Preeclampsia, Gestational hypertension, Proteinuria, Lipid profile, Minerals, Oxidative stress.

INTRODUCTION

Preeclampsia is a progressive pregnancy disorder that presents as new onset hypertension after 20 weeks of gestation with one or more of the following features: Significant proteinuria or maternal organ dysfunction such as renal insufficiency, liver involvement, and neurological or haematological complications.1 It affects 2-10% of pregnancies worldwide with an incidence of 2.4% in Pakistan.2 It accounts for 15% of preterm birth, moreover, growth retardation, encephalopathy, and other complications of premature birth may be encountered. According to the community-level interventions for preeclampsia (CLIP) trial, 17% of maternal deaths are attributable to hypertensive disorders.3
 

The exact cause of preeclampsia is unknown. Clinicians and researchers are developing tests and methods for early detection and diagnosis, and providing close monitoring and optimal management to minimise its negative consequences.

Numerous theories explain the aetiology and pathogenesis of preeclampsia, with the widely accepted two-stage model, suggesting improper placentation and both maternal and foetal factors. These factors alter maternal systemic endothelial function, causing an exaggerated inflammatory response and oxidative stress.4 This systemic inflammation and oxidative stress lead to the formation of reactive oxygen species (ROS) and reactive nitrogen species (RNS). When ROS or RNS combine with nitric oxide (NO), they form peroxynitrite, a harmful molecule that can cause cell destruction and endothelial cell death.5

An imbalance between lipid peroxidation and antioxidant mechanisms in preeclampsia impairs normal endothelial function.6 This occurs when low-density lipoprotein (LDL) is oxidised by ROS in arterial intima micro-domains, converting LDL into foam cells that cause vascular endothelial damage. Oxidative stress and lipid peroxidation are central to the placental and endothelial dysfunction, leading to hypertension and other preeclampsia complications.7 Changes in lipid profile and lipid peroxidation are positively correlated with endothelial dysfunction, with triglycerides (TGs), total cholesterol (TC), and low-density lipoprotein-cholesterol (LDL-C) levels showing a marked rise in preeclampsia compared to a normal pregnancy.8

Electrolytes play a crucial role in regulating blood pressure, and their disruption can cause vessels to become hyper-responsive to vasoconstrictors such as vasopressin and antidiuretic hormone (ADH), leading to hypertension in preeclampsia.9 An imbalance in sodium (Na) and potassium (K) levels contributes to the development of preeclampsia.10 Additionally, magnesium is believed to alter angiogenic and inflammatory responses, leading to decreased vascular contraction and reduced hypertension in preeclampsia.11 Women with preeclampsia have im-paired calcium and magnesium homeostasis and metabolism.12

Timely detection of these parameters can help healthcare professionals intervene in the disease progression to complicated preeclampsia and appropriately manage symptoms of the disease. The present study aimed to estimate biochemical and oxidative biomarkers in the population of Southern Punjab, Pakistan.

METHODOLOGY

A cross-sectional analytical study was conducted at the Quaid-e-Azam Medical College / Bahawal Victoria Hospital, Bahawalpur, after obtaining ethical approval from the Institutional Review Board. The study included 228 subjects: 114 preeclampsia patients and 114 normal pregnant women as controls from the Obstetrics and Gynaecology Department. Preeclampsia was identified by blood pressure over 140/90 mmHg and proteinuria levels exceeding 300 mg/24 hours or a +1 on dipstick test. Hospitalised individuals were approached directly, and sociodemographic information was gathered from both patients and their attendants. Data collection followed a consecutive sampling method based on inclusion and exclusion criteria. Women aged 20 to 45 years with singleton pregnancies, who developed hypertension (SBP >140 mmHg or DBP >90 mmHg on two occasions 6 hours apart) and proteinuria (>300 mg/24 hours or +1 on dipstick) during pregnancy, were included. Exclusions were made for women with chronic hypertension, gestational diabetes, cardiovascular disorder, renal disease, immunological disorders, PCOS, metabolic disorders, multiple pregnancies, or incomplete information. Written informed consent was obtained from all participants and confidentiality was maintained.

A 5 ml blood sample was collected from the median cubital vein using aseptic techniques and transferred to vacutainers without additives. After centrifugation at 3000 rpm for 10 minutes, serum was separated and stored in Eppendorf tubes at -20°C. Serum lipid profile and Ca++ and Mg++ levels were measured using a Beckman coulter AU-680 chemistry analyser through the spectrophotometric method. Serum electrolytes were analysed using an Easylyte analyser with the ion-selective electrode (ISE) potentiometer method. Oxidative stress enzyme levels were determined manually following protocols by different scientists. The lipid peroxidation marker MDA (2.02-4.65 nmol/ml) was assessed using Ohkawa's procedure and catalase levels (0.1-1.0 µmol/ml) were estimated using Aebi's method.13 Glutathione peroxidase (Glt-Px, 1.1-8.7 mg/ml) was measured following Tietze's enzymatic recycling protocol. The Kakkar’s method determined superoxide dismutase (1.3-3.5 ng/ml).14 All tests were personally performed by the principal investigator in the Pathology / Biochemistry Laboratory at the Quaid-e-Azam Medical College / Bahawal Victoria Hospital, Bahawalpur, with costs covered by the authors.

The data were analysed with the help of SPSS version 25.0. Mean and standard deviation (SD) were calculated for quantitative variables that were normally distributed. For qualitative variables, frequencies and percentages were given and presented in tabular form. Student’s t-test was performed to compare both groups. A 95% confidence interval was calculated. Pearson’s correlation was applied between the clinical / demographic and biochemical parameters of the participants. The results were considered significant when the p-value was less than 0.05.

RESULTS

This study showed significant variation in demographic, biochemical, and oxidative parameters. The findings (mean ± SD and 95% CI) of these parameters are summarised in Table I.

Table I: Mean (SD) and 95% CI of the biochemical and oxidative parameters of preeclampsia subjects and normotensive pregnant women.
 

Parameters

Control (114)

Cases (114)

p-value

Mean ± SD

95% CI

Mean ± SD

95% CI

Upper

Lower

Upper

Lower

Demographic characteristics

      Age (years)

30.0 ± 5.78

31.084

28.916

27.82 ± 6.36

29.012

26.628

0.007

      Gestational age (weeks)

30.21 ± .32

30.842

26.628

31.45 ± 2.81

31.988

30.932

0.003

      Weight (Kg)

74.04 ± 7.06

71.362

68.718

81.63 ± 8.00

83.128

80.132

<0.001

      BMI

26.83 ± 3.16

27.422

26.238

29.51 ± 2.96

30.076

28.964

<0.001

      SBP (mm/Hg)

124.99 ± 3.12

125.574

124.406

166.25 ± 11.21

168.352

164.148

<0.001

      DBP (mm/Hg)

83.64 ± 1.80

83.988

83.312

92.80 ± 6.55

94.038

91.582

<0.001

Lipid profile and LDH estimation

      Cholesterol (mg/dl)

174.88 ± 13.50

177.418

172.362

210.14 ± 20.40

213.962

206.318

<0.05

      Triglyceride (mg/dl)

184.65 ± 12.30

186.992

182.328

214.90 ± 15.59

218.806

210.994

<0.05

      LDL (mg/dl)

70.92 ± 2.62

73.224

68.616

101.78 ± 2.72

104.700

98.86

<0.05

      HDL (mg/dl)

40.08 ± 12.45

40.58

39.6

36.23 ± 20.85

36.75

35.73

<0.05

Estimation of oxidative stress parameters

-

      MDA (nmol/ml)

0.92 ± 0.12

0.951

0.904

2.58 ± 0.40

2.658

2.50

<0.05

      Catalase (µmol/mol)

1.19 ± 0.09

1.206

1.174

1.70 ± 0.14

1.726

1.674

<0.05

      SOD (ng/ml)

1.70 ± 0.05

1.708

1.692

2.56 ± 0.25

2.606

2.514

<0.05

      Glt-Px (mg/dl)

1.51 ± 0.37

1.581

1.44

3.20 ± 0.32

3.264

3.141

<0.05

Estimation of minerals and electrolytes

-

      Mg (mg/dl)

2.40 ± 0.25

2.449

2.357

1.37 ± 0.35

1.432

1.302

<0.05

      Ca (mg/dl)

8.69 ± 0.54

8.796

8.595

7.55 ± 0.42

7.632

7.474

<0.05

      Na (mEq/L)

137.35 ± 3.04

137.928

136.792

147.55 ± 4.26

148.348

146.752

<0.05

       K (mEq/L)

3.78 ± 0.26

3.834

3.737

3.15 ± 0.37

3.192

3.052

<0.05

Student’s t-test was applied to compare the means of the two groups.


Table II: Pearson’s correlation of demographical / clinical parameters with biochemical and oxidative parameters.
 

Parameters

Age

Gest. Age

BMI

S-BP

D-BP

r

p-value

r

p-value

r

p-value

r

p-value

r

p-value

Cholesterol

Case

-0.042

0.654

-0.131

0.166

0.144

0.127

0.213*

0.023

0.189*

0.023

Cont.

0.720

0.449

-0.049

0.607

-0.131

0.165

-0.082

0.385

0.028

0.767

TG

Case

0.049

0.604

0.243**

0.009

0.011

0.910

0.368**

<0.001

0.276**

0.001

Cont.

0.480

0.610

0.206*

0.028

0.019

0.839

0.016

0.865

-0.050

0.595

LDL-C

Case

0.086

0.365

0.085

0.369

0.106

0.261

0.121

0.199

0.166

0.017

Cont.

0.750

0.425

-0.169

0.072

0.100

0.290

-0.179

0.057

0.032

0.811

HDL-C

Case

-0.009

0.925

0.186*

0.048

0.049

0.608

0.019

0.838

0.021

0.827

Cont.

0.180

0.851

0.098

0.300

-0.580

0.538

-0.165

0.080

0.053

0.575

MDA

Case

0.021

0.822

0.835**

<0.001

0.408**

<0.001

0.190*

0.043

0.210*

0.025

Cont.

-0.047

0.620

0.680**

<0.001

-0.016

0.870

0.131

0.163

-0.145

0.123

SOD

Case

0.015

0.873

0.753**

<0.001

0.344**

<0.001

0.166

0.077

 0.009

0.923

Cont.

-0.187*

0.046

0.114

0.226

-0.035

0.718

-0.151

0.108

0.044

0.639

Catalase

Case

0.006

0.951

0.012

0.896

0.267**

0.004

0.043

0.699

-0.110

0.245

Cont.

-0.235

0.012

0.080

0.399

0.003

0.973

0.013

0.888

-0.016

0.870

Glt-Px

Case

-0.050

0.959

0.247

0.008

0.169

0.073

0.021

0.828

0.175

0.063

Cont.

0.173

0.066

-0.105

0.268

0.159

0.091

-0.011

0.911

-0.074

0.435

Na

Case

0.083

0.378

0.286**

0.000

0.030

0.754

-0.118

0.181

-0.121

0.827

Cont.

0.162

0.086

0.222

0.018

-0.024

0.799

-0.037

0.585

-0.179

0.057

K

Case

0.081

0.394

-0.483**

0.000

-0.278*

0.003

-0.187

0.181

-0.107

0.257

Cont.

0.050

0.600

0.235**

0.002

0.031

0.746

-0.007

0.941

0.109

0.248

Mg

Case

0.079

0.404

-0.555**

<0.001

-0.222*

0.017

-0.134

0.157

-0.169

0.081

Cont.

0.034

0.721

-0.148

0.115

0.056

0.554

0.036

0.702

0.180

0.055

Ca

Case

0.005

0.957

0.028

0.768

0.024

0.801

0.368**

0.000

0.290**

0.002

Cont.

-0.007

0.943

-0.038

0.692

-0.097

0.306

-0.064

0.499

0.081

0.390

*Slightly significant, **highly significant.

Pearson’s correlation analysis revealed significant associations within various parameters across different domains. Detailed correlations are delineated in Table II.

DISCUSSION

The comprehensive assessment of lipid profile including TC, TGs, LDL-C, and HDL-C levels, alongside essential minerals such as sodium, potassium, magnesium, and calcium, underscores the multifactorial nature of preeclampsia. Furthermore, the investigation into antioxidant enzymes, including malondialdehyde (MDA), superoxide dismutase, catalase, and glutathione peroxidase levels, sheds light on the oxidative stress component inherent in this pregnancy-related disorder.

Considering lipid profile preeclamptic pregnant women in the present study had considerably lower HDL-C levels (p <0.05) than normal pregnant women. This finding relates with several other research studies conducted worldwide. In a population-based study conducted in Australia, it was discovered that preeclampsia patients had lower HDL levels than typical pregnant women.15 Results from a different study carried out in Africa were comparable as well.16 In the present study, the concentrations of TGs, LDL-C, and TC were shown to be considerably higher in preeclamptic women than in normal pregnant women. According to a study by Kockx et al., preeclamptic patients had considerably higher blood TGs and free fatty acids levels.15 Tesfa et al. also demonstrated a link between preeclampsia and elevated TG and LDL-C levels in the African population.16 Bhat et al. revealed similar findings in the Indian population.17 Li et al. also revealed similar results in the Chinese population.18 Pearson’s correlation between clinical and biochemical parameters indicated that gestational age exhibits a positive correlation with TGs in both cases and controls, while systolic blood pressure (SBP) and diastolic blood pressure (DBP) demonstrate significant positive correlations with TC and TGs specifically in the case group. A study by Ebogo-Belobo et al., conducted in Africa, and Ephraim et al. in Ghana, showed that TC and LDL-C are associated with blood pressure, indicating a complex interplay of lipid parameters in the endothelial damage associated with disease pathogenesis.7,8

In the present investigation, all the oxidative stress enzymes (MDA, SOD, catalase, and glutathione peroxidase) were elevated in preeclampsia patients as compared to the controls. This increase indicates elevated oxidative stress since it shows that preeclampsia is associated with significant persistent lipid peroxidation. A study by Gohil et al. in India showed similar results.19 Alkuraishy et al. revealed considerable increases in MDA levels in preeclampsia.20 Decreased glutathione levels were seen in the study conducted by Ahmad et al.21 Lin et al. in China described the elevated SOD levels as a predictive feature of pre-eclampsia.22 In the present study, the Pearson’s correlation analysis revealed a significant association of MDA with blood pressure. Yanglem et al. revealed the similar find-ings.23

Discussing electrolyte levels in the present study, magnesium, calcium, and potassium were decreased while sodium was increased in preeclampsia patients as compared to the controls. A study in the Indian population by Basavaraj et al. also found the similar results.24 The decreased levels of calcium and magnesium were also reported by Aslam et al. in preeclamptic patients in the South-Punjab region of Pakistan.25 Pearson’s correlation analysis showed a significant correlation of calcium and magnesium with blood pressure measurements, thus indicating their association with the severity of the disease. Similar findings were reported by Al-Jamil et al. in the Saudi population.9

Although the study has identified notable findings, it also has certain limitations such as being conducted in a single hospital. This may not represent the entire Pakistani population, potentially leading to ethnic bias. Additionally, the oxidative stress tests used are costly and not widely accessible.

CONCLUSION

The study indicates significant alterations in lipid profile, minerals, and oxidative stress in preeclampsia patients. Specifically, TC and TGs within the lipid profile, calcium (Ca) and magnesium (Mg) among minerals, and MDA as an oxidative stress marker, all showed a significant association with blood pressure. These findings suggest that these parameters could serve as potential biomarkers for preeclampsia.

ETHICAL APPROVAL:
Ethical approval was obtained from the Institutional Review Board and Ethical Committee of the Quaid-e-Azam Medical College, Bahawalpur, Pakistan, vide letter no. 1800/DME/ QAMC, Dated: 13-July-2022.

PATIENTS’ CONSENT:
Informed consent was obtained from all the patients.

COMPETING INTEREST:
The authors declared no conflict of interest.

AUTHORS’ CONTRIBUTION:
MNN, UM, NS, SY: Concept of the study, study design, data collection, draft of the manuscript, statistical analysis, data interpretation, and literature search.
All authors approved the final version of the manuscript to be published.

REFERENCES

  1. National institute for health and care excellence. Hypertension in pregnancy: Diagnosis and management. Clinical Guideline [Internet]. London: NICE; 2019. Available from: https://www.nice.org.uk/guidance/cg107.
  2. Magee LA, Sharma S, Nathan HL, Adetoro OO, Bellad MB, Goudar S, et al. The incidence of pregnancy hypertension in India, Pakistan, Mozambique, and Nigeria: A prospective population-level analysis. PLoS Med 2019; 16(4): e1002 783. doi: 10.1371/journal.pmed.1002783.
  3. Aukes AM, Arion K, Bone JN, Ching C, Devkota S, Fisher B, et al. Causes and circumstances of maternal death: A secondary analysis of the community-level interventions for preeclampsia (CLIP) trials cohort. Lancet Glob Health 2021; 9(9):e1242-51. doi: 10.1016/S2214-109X(21)00263-1.
  4. Al-Jameil N, Aziz Khan F, Fareed Khan M, Tabassum H, Ali MN, Al-Rashed M, et al. A brief overview of preeclampsia. J Clin Med Res 2014; 6(1):1-7. doi: 10.14740/jocmr1625w.
  5. Jung E, Romero R, Yeo L, Gomez-Lopez N, Chaemsaithong P, Jaovisidha A, et al. The etiology of preeclampsia. Am J Obstet Gynecol 2022; 226(2S):S844-66. doi: 10.1016/ j.ajog. 2021.11.1356.
     
  6. Mannaerts D, Faes E, Cos P, Briede JJ, Gyselaers W, Cornette J, et al. Oxidative stress in healthy pregnancy and preeclampsia is linked to chronic inflammation, iron status, and vascular function. PLoS One 2018; 13(9):e0202919. doi: 10.1371/journal.pone.0202919.
  7. Ebogo-Belobo JT, Bilongo CM, Voufo RA, Atembeh-Noura E, Djabidatou O, Kenfack MT, et al. Maternal serum lipids in some women with pre-eclampsia in Yaounde. Pan Afr Med J 2021; 39:14. doi: 10.11604/pamj.2021.39.14.22734.
  8. Ephraim R, Doe P, Amoah S, Antoh E. Lipid profile and high maternal body mass index is associated with preeclampsia: A case-control study of the cape coast metropolis. Ann Med Health Sci Res 2014; 4(5):746-50. doi: 10.4103/2141- 9248.141542.
  9. Al-Jameil N, Tabassum H, Ali MN, Qadeer MA, Khan FA, Al-Rashed M. Correlation between serum trace elements and risk of preeclampsia: A case controlled study in Riyadh, Saudi Arabia. Saudi J Biol Sci 2017; 24(6):1142-8. doi: 10. 1016/j.sjbs.2015.02.009.
  10. Owusu Darkwa E, Djagbletey R, Antwi-Boasiako C, Kwawukume EY, Owiredu WK, Ankra-Badu G, et al. Serum sodium and potassium levels in preeclampsia: A case-control study in a large tertiary hospital in Ghana. Cogent Med 2017; 4(1):1306395. doi: 10.1080/2331205X.2017.1306 395.
  11. Lumbers ER, Delforce SJ, Arthurs AL, Pringle KG. Causes and consequences of the dysregulated maternal renin-angiotensin system in preeclampsia. Front Endocrinol (Lausanne) 2019; 10:563. doi: 10.3389/fendo.2019.00563.
  12. Owusu Darkwa E, Antwi-Boasiako C, Djagbletey R, Owoo C, Obed S, Sottie D. Serum magnesium and calcium in preeclampsia: A comparative study at the Korle-Bu Teaching Hospital, Ghana. Integr Blood Press Control 2017; 10:9-15. doi: 10.2147/IBPC.S129106.
  13. Tiwari, AK, Mahdi AA, Zahra F. Chandyan S, Srivastava VK, Negi MP. Evaluation of oxidative stress and antioxidant status in pregnant anemic women. Indian J Clin Biochemist 2010; 25(4):411-8. doi: 10.1007/s12291-010-0067-1.
  14. Ramesh KSV, Swetha P, Mohan Kumar P, Sruthima NVS, Naresh Kumar C. Estimation of superoxide dismutase levels in saliva and gingival crevicular fluid among smokers and non-smokers in periodontitis patients: An observational study.  J Nigeria Med Assoc 2019; 60(3):133-7. doi: 10.4103/ nmj.NMJ_56_19.
  15. Kockx M, Roberts L, Wang J, Burke P, Rye KA, Quinn CM, et al. Effects of pre-eclampsia on HDL-mediated cholesterol efflux capacity after pregnancy. Atheroscler Plus 2022; 31(48): 12-9. doi: 10.1016/j.atherosclerosis.2022.09.012.
  16. Tesfa E, Nibret E, Munshea A. Maternal lipid profile and risk of pre-eclampsia in African pregnant women: A systematic review and meta-analysis. PLoS One 2020; 15(12): e0243538. doi: 10.1371/journal.pone.0243538.
  17. Bhat PV, Vinod V, Priyanka AN, Kamath A. Maternal serum lipid levels, oxidative stress and antioxidant activity in pre-eclampsia patients from Southwest India. Pregnancy Hypertens 2019; 15:130-3. doi: 10.1016/j.preghy.2018. 12.010.
  18. Li J, Lu J, Wang M, Hu W, Jin N, Li X, et al. Predictive value of second-trimester maternal lipid profiling in early-onset pre-eclampsia: A prospective cohort study and nomogram. Front Med (Lausanne) 2021; 8:688312. doi: 10.3389/fmed.2021.688312.
  19. Gohil JT, Patel PK, Gupta P, Shah MH, Gandhi VP, Patel NH, et al. Evaluation of oxidative stress and antioxidant defense in subjects of preeclampsia. J Obstet Gynaecol India 2011; 61(6):638-40. doi: 10.1007/s13224- 011-0099-2.
  20. Al-Kuraishy HM, Al-Gareeb AI, Al-Maiahy TJ. Concept and connotation of oxidative stress in preeclampsia. J Lab Physicians 2018; 10(3):276-82. doi: 10.4103/JLP.JLP_26_18.
  21. Ahmad IM, Zimmerman MC, Moore TA. Oxidative stress in early pregnancy and the risk of preeclampsia. Pregnancy Hypertens 2019; 18:99-102. doi: 10.1016/j.preghy.2019. 09.014.
  22. Lin Y, Yu X, Xu R, Li L, Wang T, Liu S, et al. Uric acid/superoxide dismutase can predict progression of gestational hypertension to preeclampsia. Cardiovasc Med 2023; 10: 1-8. doi: 10.21037/cdt-22-321.
     
  23. Yanglem A, Koch N, Naorem S, Kshetrimayum R, Kamei G, Nongmaithem B, et al. Serum malondialdehyde and serum glutathione peroxidase levels in pregnant women with and without preeclampsia. Int J Reprod Contracept Obstet Gynecol 2023; 12:3294-8. doi: 10.18203/2320-1770.ijrcog 20233297.
  24. Basavaraj V, Archana H, Bhagyajyoti N, Sunitha G, Ravi S, Shashidhar HB, et al. Study of serum electrolytes, calcium, and magnesium in preeclampsia at a tertiary hospital in central Karnataka. Int J Clinical Biochem 2021; 8(2):145-9. doi: 10.1093/jbcr/irab026.
  25. Aslam F, Hayat I, Zakir FA, Haider SS, Shams Un Nisa, Sadaf Un Nisa, et al. Comparative analysis of serum calcium and magnesium as a better predictor in cases of mild and severe pre-eclampsia. Professional Med J 2020; 27(8): 1722-7. doi: 10.29309/TPMJ/2020.27.08.4228.